Dr. Lal Path Labs Ltd. has informed the Exchange regarding allotment of 83775510 securities by the Board pursuant to Bonus Issue through circular resolution on December 22, 2025
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has allotted 83,775,510 equity shares to existing shareholders through a Bonus Issue, approved via a circular resolution by the Board on December 22, 2025. A bonus issue rewards current shareholders with free additional shares, increasing the total share base of the company. The exact bonus ratio is not specified in this particular filing. Shareholders who held the stock on the record date will receive the bonus shares in their demat accounts.
The share price typically adjusts downward on the ex-bonus date in proportion to the bonus ratio, while overall shareholder value remains unchanged. Shareholders effectively hold more shares, improving liquidity and affordability of the stock.